Navigation Links
Chuback Medical Group Raises Awareness for the Serious Vein Condition Deep Vein Thrombosis
Date:3/19/2013

tment options. Each patient is carefully evaluated to identify the best vein treatment plan to meet their unique needs. Whenever possible, the vein center will recommend conservative treatment as a first step. This may include using compression stockings or making healthy lifestyle changes. If additional treatment for vein disease is needed, Chuback Medical Group provides leading edge therapies including sclerotherapy, phlebectomy, and endovenous laser ablation.

Patients can also find useful educational information about vein disease on the clinic’s website. That includes easy-to-understand explanations of common vein conditions, symptoms, and treatments. At Chuback Medical Group, the focus is on providing the best vein treatment care in Bergen County, NJ.

About Chuback Medical Group

Chuback Medical Group is a leading care provider specializing in vein disorders, aesthetic services, and medical weight loss. Located in Bergen County, New Jersey, the clinic strives to provide patients with customized care for the face and body, using safe and effective noninvasive and minimally invasive therapies. The highly trained medical staff has extensive knowledge and expertise treating vein disorders such as varicose veins and spider veins, as well as in cosmetic medicine and healthy weight loss. Medical Director and chief vein specialist Dr. John Chuback, MD, is a leading expert in the treatment of varicose veins using minimally invasive laser technology, and a decorated provider of superior patient care for the full range of vein conditions.

Chuback Medical Group
Tel. 201-693-4847

Read the full story at http://www.prweb.com/releases/2013/3/prweb10519027.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related medicine news :

1. Presidents Bioethics Commission releases report on pediatric medical countermeasure research
2. Rejuv Medical Sponsoring Minnesota’s Annual iRock Run
3. M.D. International Studies Innovative Pre-Medical Courses Arrives in USA
4. Cloud Medical Doctor Software Corporation Finalizes Acquisition of Doctors Network of America and Expands its Medical Billing Services West
5. Innovative Medical Marijuana Growing Product added to PotLocator.com Lineup
6. Health2Go Announces Medical Research Showing DHEA Improves Health and Benefits Skin
7. Medical Marketing Firm MCPR Introduces Sports Medicine Expert for Media Interviews
8. UH Case Medical Center awarded highest certification as Comprehensive Stroke Center
9. Peter Piot awarded Hideyo Noguchi Africa Prize for Medical Research
10. Corporate Whistle Blower Center Urges Physicians To Call them--If They Have Proof A Medical Device Company Was Knowingly Selling Defective Products
11. Launch of Chinese-German Center for Bio-Inspired Materials at Mainz University Medical Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... use among young people has spiked, with 29.3 percent ... at least once and 17 percent admitting to regular use ... ‘Yes to Life,’ volunteers from the Church of Scientology of ... information about drugs, to help reverse this alarming trend. , ... Say ‘Yes’ to Life,” volunteers have distributed 40,000 copies of ...
(Date:8/1/2014)... appetite and whole-body metabolism. A protein known as PPARγ ... and body weight, but the identity of the neurons ... new study in the Journal of Clinical Investigation ... neuron known as pro-opiomelanocortin (POMC) neurons is critical in ... and colleagues at Yale University School of Medicine found ...
(Date:8/1/2014)... FRIDAY, Aug. 1, 2014 (HealthDay News) -- The U.S. ... approved a new drug, Jardiance, to help fight type ... alone or added to existing treatment regimens to control ... Dr. Curtis Rosebraugh, director of the Office of Drug ... and Research, said in an agency statement. The ...
(Date:8/1/2014)... Summer is here, and with it comes the season of ... can be a pain for dogs. Animal Emergency & Referral ... get rid of ticks and prevent them completely. , Female ... which is why they are so active during this season. ... and carry a number of diseases, including lyme disease, babesiosis ...
(Date:8/1/2014)... of a cancer diagnosis may improve health outcomes for ... by a researcher at the University of Houston (UH). ... intervention is the writing instruction. Otherwise, writing is just ... journal can be therapeutic, but oftentimes we don,t get ... not," said Qian Lu, assistant professor and director of ...
Breaking Medicine News(10 mins):Health News:Addressing a Serious Issue Affecting German Teens 2Health News:FDA Approves New Type 2 Diabetes Drug 2Health News:Tis the Season for Tick Prevention 2Health News:Expressive writing may help breast cancer survivors 2Health News:Expressive writing may help breast cancer survivors 3
... Core Administration Software with ... PLANO, Texas, May 15 Perot Systems (NYSE:,PER) ... Core,Administration Software. Xcelys 5.0 software is a continuance of ... health plan market., Xcelys, formerly called PERADIGM software, ...
... of shingles cases, expert says , , THURSDAY, May ... older should be vaccinated against shingles, a condition that ... Disease Control and Prevention recommended on Thursday. , This ... 2006, after the ZOSTAVAX vaccine was approved by the ...
... pump inhibitors (PPIs) to control gastroesophageal reflux disease ... take them continue to experience breakthrough, which is ... regurgitation and heartburn. These breakthrough symptoms lead more ... (OTC) remedies, according to a survey recently conducted ...
... YORK, May 15 Pharmaceutical research and,development (R&D) is ... years and,a billion dollars of investment to turn a ... journey from discovery to market, is filled,with challenges. For ... makes it to the market. "From Molecule to Medicine," ...
... that,the U.S. Court of Appeals for the Federal Circuit ... District Court for the Central District of,California in the ... As a result of the Court of Appeals, ruling, ... Sanofi-aventis is considering all its legal options., While ...
... Diabetes,Wholesale (ADW), a discount provider of diabetic supplies, is ... network. ADW hopes to,expand its online reach and strengthen ... affiliate partners a percentage of every sale they refer.,Commissions ... our affiliate,program as a great way to cultivate an ...
Cached Medicine News:Health News:Perot Systems Announces the Launch of Xcelys(TM) 5.0 Software 2Health News:CDC Recommends Shingles Vaccine for Those Over 60 2Health News:CDC Recommends Shingles Vaccine for Those Over 60 3Health News:Nearly 40 percent of GERD patients taking PPIs experience recurring symptoms 2Health News:Nearly 40 percent of GERD patients taking PPIs experience recurring symptoms 3Health News:District Court Decision Affirmed in U.S. Lovenox(R) (enoxaparin sodium) Patent Infringement Case 2Health News:American Diabetes Wholesale Launches Affiliate Program 2
(Date:8/1/2014)... Calif. , Aug. 1, 2014  Isis Pharmaceuticals, ... initiation of a pivotal Phase 3 study evaluating ISIS-SMN ... the most common genetic cause of infant mortality. Isis ... within the next few weeks, at which time Isis ... development partner, Biogen Idec. The Phase 3 study, ENDEAR, ...
(Date:8/1/2014)... Aug. 1, 2014 Inovio Pharmaceuticals, Inc. (NYSE ... conference call to report its second quarter 2014 financial ... ET. CEO Dr. J. Joseph Kim and ... earnings, provide a corporate update, and participate in a ... development plans for VGX-3100, Inovio,s immune therapy targeting pre-cancers ...
(Date:8/1/2014)... Aug. 1, 2014 Arena Pharmaceuticals, Inc. ... corporate update and reported financial results for the ... "We have continued to see encouraging advancements ... 43% quarter-over-quarter increase in estimated total prescriptions and ... mark," said Jack Lief, Arena,s President and Chief ...
Breaking Medicine Technology:Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Infants with Spinal Muscular Atrophy 2Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Infants with Spinal Muscular Atrophy 3Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Infants with Spinal Muscular Atrophy 4Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-SMN Rx in Infants with Spinal Muscular Atrophy 5Inovio Pharmaceuticals to Host Second Quarter 2014 Financial Results Call on August 11, 2014 2Inovio Pharmaceuticals to Host Second Quarter 2014 Financial Results Call on August 11, 2014 3Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 2Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 3Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 4Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 5Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 6Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 7Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 8Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 9Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 10Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 11
Microalbumin Linearity Control...
Total IgE Control...
The K-ASSAY Lipid Controls are assayed controls produced from fresh human sera to monitor the accuracy and precision of quantitative lipid determinations of human sera specimens....
The K-ASSAY hs-CRP Control Set is intended to be used as a consistent test sample of known concentrations for monitoring the performance of hs-CRP (high sensitive C-Reactive Protein) immunoturbimetri...
Medicine Products: